Sapient

Sapient is a private biotech and bioanalytics company that provides multi-omics biomarker discovery and translational research services for biopharma and biotech customers. The company combines high-throughput mass spectrometry, proteomics, metabolomics, lipidomics, cytokine profiling, and AI-driven biocomputational analysis to identify biomarkers, drug targets, and clinical signatures. Sapient also leverages a large proprietary human biology database and its DynamiQ platform to support target identification, biomarker validation, and patient stratification. Rather than developing its own therapeutic pipeline, the company operates as an insight and services partner intended to de-risk and accelerate drug discovery and clinical development. It appears to have CLIA/CAP-accredited laboratory capabilities and offers discovery, translational, and clinical-stage support.